Following the FDA approval, PFE's Hympavzi becomes the first hemophilia medicine approved in the United States to be ...

Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and ...

The approval of Hympavzi makes it the first treatment for both hemophilia A and B to be administered through a pre-filled pen ...

The FDA has approved a new preventive treatment for people with certain types of hemophilia that can reduce bleeding episodes, sometimes down to just a few per year.

H. Lundbeck plans to acquire Longboard Pharmaceuticals in a $2.6 billion deal, the companies announced Monday.

More bystanders are stepping in to administer naloxone to people who've overdosed on opioids, a new study shows.

A simple tweak in available vial sizes of the breakthrough Alzheimer's drug Leqembi could save Medicare hundreds of millions ...

Danish CNS specialist Lundbeck today revealed that it has reached to acquire Longboard Pharmaceuticals. Lundbeck said it will ...

GSK's depemokimab met key endpoints in phase 3 trials for chronic rhinosinusitis with nasal polyps (CRSwNP), showing promise ...

One doctor spoke out warning that women may be getting misdiagnosed with a common condition when they may actually be ...

Cancer Research UK hailed the shift as the biggest improvement in cervical cancer treatment in more than 20 years ...

Labcorp Holdings Inc. LH, or Labcorp, is slated to report its third-quarter 2024 results on Oct. 24, before the market opens.